SkinHealth Systems Inc.
SKIN | NASDAQ
$0.68
+$0.01 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$0.68
-$0.01 (-0.74%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Company Profile
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Key Executives
| Name | Position |
|---|---|
| Pedro Malha | President, Chief Executive Officer & Director |
| Michael Monahan | Chief Financial Officer |
| Kelly Pennington | Senior Vice President of Americas |
| Paul Bokota | Senior Vice President & General Counsel |
| Sheri Lewis | Chief Operations, Quality & Technology Officer |
| Tanja Wirtz | Senior Vice President of International |
| Whitney Cypes | Chief Brand & Clinical Innovation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | DEFA14A | Filing |
| Aug 12, 2026 | DEF 14A | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 31, 2026 | PRE 14A | Filing |
| Jul 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 17, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
SkinHealth Systems Inc.
| Country | United States |
| IPO Date | Nov 23, 2020 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 613 |
| CEO | Pedro Malha |
Contact Details
3600 E. Burnett Street Long Beach,
California 90815 United States
Stock Details
| Ticker Symbol | SKIN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001818093 |
| CUSIP Number | 88331L108 |
| ISIN Number | US88331L1089 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove SKIN